CN104987412A - Arsenic-IgE chelate as well as preparation method and application thereof - Google Patents

Arsenic-IgE chelate as well as preparation method and application thereof Download PDF

Info

Publication number
CN104987412A
CN104987412A CN201510413294.5A CN201510413294A CN104987412A CN 104987412 A CN104987412 A CN 104987412A CN 201510413294 A CN201510413294 A CN 201510413294A CN 104987412 A CN104987412 A CN 104987412A
Authority
CN
China
Prior art keywords
ige
arsenic
inner complex
sample
chromatography column
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510413294.5A
Other languages
Chinese (zh)
Inventor
张积仁
阳帆
董欣敏
吴婧
蔡睿
孙遥
赵乙木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Baihao Biotechnology Co Ltd
Original Assignee
Shanghai Baihao Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Baihao Biotechnology Co Ltd filed Critical Shanghai Baihao Biotechnology Co Ltd
Priority to CN201510413294.5A priority Critical patent/CN104987412A/en
Publication of CN104987412A publication Critical patent/CN104987412A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses an arsenic-IgE chelate as well as a preparation method and application thereof. The arsenic-IgE chelate is formed by chelating arsenic ions with IgE through sulfydryl or/and cysteine residues. According to the invention, a qualitative and quantitative detection method of the arsenic-IgE chelate is established for favorably quantitatively detecting the application of the arsenic-IgE chelate to the evaluation of the arsenic pollution degree of one region. By quantitatively detecting the arsenic-IgE chelates in serums of people in one region, the condition that people in the region are polluted by arsenic can be indirectly reflected, and further the arsenic pollution degree of the region is indirectly reflected. According to the quantitative detection method for the arsenic-IgE chelate, established by the invention, the accuracy is greatly improved, and the detection repeatability is greatly improved.

Description

A kind of arsenic-IgE inner complex and its preparation method and application
Technical field
The present invention relates to detection field, more particularly, relate to a kind of arsenic-IgE inner complex and its preparation method and application.
Background technology
IgE produces primarily of mucosa-associated lymphoid tissue, and wherein major part is that small part is synthesized by respiratory tract, sialisterium and genital tract mucosal tissue synthesized by gastrointestinal lymphoid sample tissue.Lactation, puerpera's glandular tissue contained a large amount of IgE generation cell, and these cells are mainly from stomach and intestine.The mankind, also has a small amount of IgE from marrow.After people is born, 4 ~ June starts to synthesize IgE, and in 4 ~ 12 years old serum, content reaches adult levels, about 10% of the total Ig of serotype IgE, about 5 ~ 6 days transformation period.IgE has IgE1 and IgE2 two subclass.IgE1 is mainly present in serum, and 85%, α 1 chain molecular weight accounting for IgE in serum is 56kD; IgE2 is mainly present in exocrine secretion, and small part exists with serotype IgE, and 15%, α 2 chain accounting for IgE in serum lacks hinge area, and molecular weight is 52kD.IgE demonomerization form in serum also has outward by forms such as the connected dimer of J chain covalency or tripolymers.The binary that secretory IgE is connected by J and secretory component formed, mainly be present in the exocrine secretions such as colostrum, saliva, tear, gastrointestinal fluid, bronchial secretion, it is the most important factor of mucous membrane local immunity, secretory IgE is by combining with corresponding pathogenic micro-organism (as poliovirus), prevent it to be adsorbed onto on permissive cell, secretory IgE also can neutralize a toxin as vibrio cholera toxin and large intestine bar toxin etc.Newborn infant easily suffers from respiratory tract, gastrointestinal tract infection may be synthesized not enough relevant with IgE.Chronic bronchitis outbreak also has certain relation with the minimizing of secretory IgE.Secretory IgE is passed to baby by colostrum by puerpera, and this is also a kind of important natural passive immunity.Eosinophilic granulocyte, neutrophil leucocyte and Expression of Macrophages Fc α R, serotype monomer I gE can mediate opsonophagocytosis and ADCC effect.In addition, secretory IgE has immunity and gets rid of function, and namely the pyrogenic substances that discharges in conjunction with soluble antigens a large amount of in diet and normal intestinal flora or pathogenic micro-organism of secretory IgE, prevents them from entering blood.
As everyone knows; arsenic (As ckel; As) closely bound up with the health of human body; first it is that human body maintains healthy necessary trace element, and it is present in multiple hydrogenase, the redox reaction of catalysis hydrogen; participate in the synthesis of multiple zymoprotein and the metabolism of cytohormone and pigment; have promote the absorption of iron and erythrocytic growth, activating enzyme to form coenzyme, strengthen Regular Insulin, hypoglycemic, protect the effects such as cardiovascular, if therefore human body lacks arsenic, the generation of disease can be caused.But true in life, due to environmental pollution, seldom lack arsenic in human body, the content of contrary arsenic is usually excessive, usually causes the generation of disease, even threat to life.
Arsenic content in vivo exceedes certain level will cause to health the infringement being difficult to recover, it can arsenic cigarette, arsenic dirt and various oxide form are taken in body by human body through respiratory tract and digestive tube, by the Competition with calcium ion, oxidative damage, the mechanism such as apoptosis, cause based on nerve, digestion, the general of hemopoietic system obstacle, gradual, persistence non-reversibility disease, and its harm also may be genetic to the next generation.Anaemia is one of early symptom of arseniasis, and arsenic can suppress the activity of many enzymes in protoheme building-up process.Arseniasis can cause vasospasm, angina abdominis, retinal arterioles spasm and hypertension, often causes tiny arteriosclerosis.The renal impairment of arsenic often shows as the pathology such as interstitial nephritis or atrophic ephritis, and reabsorption function reduction is early stage symptom.Arsenic contact also may affect reproductive function, and the probability of women's generation Infertility of Exposed To Arsenic, miscarriage and stillborn foetus increases, and by with it placental metastasis to fetus.Per os arseniasis person liver is one of main damaged organ, hepatomegaly can be caused to present jaundice, even liver cirrhosis or hepatic necrosis, and hepatic injury may be that in liver, arteriolospasm causes caused by local asphyxia.Arsenic causes Porphyrin Metabolism obstacle, suppresses containing sulfydryl enzyme, interference vegetative nerve.
In close relations between arsenic and multiple proteins, can be combined with multiple proteins, suppress the activity of multiple protein enzyme.Along with going deep into arsenic toxicity research, people recognize that the interaction of arsenic and albumen plays important role in its intoxicating process gradually, be considered to the key point of toxicity mechanism understanding arsenic, therefore, the research of arsenic and protein interaction just seemed ever more important.And the present mechanism about arsenic and protein effect is only tip of the iceberg, also has the relation between a lot of protein and arsenic not clear, thus strengthen for the relation between arsenic and protein most important.
Summary of the invention
For the with serious pollution problem of arsenic, the object of the present invention is to provide a kind of arsenic-IgE inner complex and preparation method thereof, and set up the qualitative and quantitative analysis method of arsenic-IgE inner complex, so that detection by quantitative arsenic-IgE inner complex is in the application of the regional arsenic pollution level of evaluation one.Indirectly can reflect by arsenic-IgE inner complex in the regional crowd's serum of detection by quantitative one situation that this regional crowd pollutes by arsenic, thus indirectly reflect this regional arsenic pollution level.
The technical solution adopted for the present invention to solve the technical problems is: provide a kind of arsenic-IgE inner complex, arsonium ion and IgE by sulfydryl or/and cysteine residues chelating forms.
The present invention also provides a kind of preparation method of above-mentioned arsenic-IgE inner complex, comprises the following steps:
A) chelatropic reaction of arsenic and IgE: add arsonium ion in the IgE coming from human body or the IgE recombinated according to biological method and carry out chelatropic reaction purifying, obtain reaction soln;
B) extraction of purifying arsenic-IgE inner complex: adopt immune-affinity chromatography, removes unreacted IgE and unnecessary arsonium ion in reaction soln, obtains arsenic-IgE inner complex.
Wherein, step B described in external synthesis method) specific as follows:
(1) sample dissolution: to through steps A) add physiological saline in the reaction soln that obtains arsenic-IgE inner complex is redissolved;
(2) balance chromatography column: use dilution buffer to rinse the pipeline of chromatography column, load in chromatography column can with the filler of IgE specific binding, after dress post, continue to use dilution buffer balance chromatography column;
(3) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (1), IgE and filler specific binding;
(4) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.05-0.1mol/L to carry out wash-out, obtain elutriant I;
(5) collect: collect elutriant I;
(6) dialyse: by the elutriant of the collection in step (5), dress dialysis tubing, uses ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample;
(7) balance chromatography column: adopt new chromatography column, use dilution buffer flushing pipeline, in this chromatography column load can with the filler of arsenic specific binding, dress post after balance chromatography column by dilution buffer again;
(8) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (6);
(9) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.5-1.0mol/L to carry out wash-out, obtain elutriant II;
(10) collect: collect elutriant II;
(11) dialyse: by the elutriant of the collection in step (10), dress dialysis tubing, uses ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample, obtain arsenic-IgE inner complex.
Wherein, the preparation method of above-mentioned arsenic-IgE inner complex, also comprises step C): to the qualification of arsenic-IgE inner complex;
Wherein, step C) in specific as follows:
(1) glue bed is prepared: prepare glue bed using the one in sepharose, polyacrylamide gel as medium;
(2) application of sample: get step B) in the arsenic-IgE inner complex that obtains of extraction purification, add dilution buffer, and mix, then application of sample is in sample cell;
(3) electrophoresis: connect electrophoresis plate, carry out electrophoresis;
(4) detect: on glue bed, find out the protein band containing arsenic, this protein band is taken out and dissolves, and then adopt ELISA method or ICP-MS method or AAS method to detect the content whether containing arsenic and detection arsenic.
The present invention also provides the application of a kind of arsenic-IgE inner complex described above in preparation human body in the reagent of arsenic-IgE inner complex or test kit.
The present invention also provides a kind of and at least comprises the test kit of arsenic-IgE inner complex described above as standard substance.
Preferably, also comprise coating buffer in this test kit, this coating buffer contains the material of catching IgE or the material of catching arsenic.
The present invention also provides a kind of method of detection by quantitative arsenic-IgE inner complex, using the above-mentioned arsenic-IgE inner complex of known content as standard substance, a pair sample of following methods is adopted to detect: euzymelinked immunosorbent assay (ELISA), enzyme linked immunological and atomic absorption spectrum combined techniques, enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques, purification arsenic-IgE inner complex and enzyme linked immunological combined techniques, purification arsenic-IgE inner complex and atomic absorption spectrum combined techniques, purification arsenic-IgE inner complex and inductivity coupled plasma mass spectrometry combined techniques, electrophoresis and enzyme linked immunological or atomic absorption spectrum or inductivity coupled plasma mass spectrometry combined techniques.
Implement arsenic-IgE inner complex of the present invention and its preparation method and application, there is following beneficial effect:
1. the present invention's external synthesis arsenic-IgE inner complex first;
2. the present invention proposes arsenic-IgE inner complex first and can be used for preparing application in the reagent or test kit detecting arsenic-IgE inner complex in blood sample.
3. the present invention establishes the method for qualitative and quantitative detection of arsenic-IgE inner complex, so that detection by quantitative arsenic-IgE inner complex is in the application of the regional arsenic pollution level of evaluation one.Indirectly can reflect by arsenic-IgE inner complex in the regional crowd's serum of detection by quantitative one situation that this regional crowd pollutes by arsenic, thus indirectly reflect this regional arsenic pollution level.Its accuracy of arsenic-IgE inner complex quantitative detecting method that the present invention sets up improves greatly, and the repeatability of detection is greatly enhanced.
Accompanying drawing explanation
Fig. 1 is the non denatured electrophoretic band figure of arsenic-IgE inner complex of the present invention;
Fig. 2 is the synchrotron radiation X line fluorometric analysis figure of the electrophoretic band of arsenic-IgE inner complex of the present invention.
Embodiment
Below, in conjunction with embodiment, the present invention is described further:
Unless otherwise indicated, the laboratory operating procedures related to is the step of this area routine in the present invention, and agents useful for same, material are as cited by following, and the reagent being this area conventional not enumerating out in the present invention maybe can be obtained by commercial mode:
Phosphate solution is 0.05-0.1mol/L Na 2hPO 4solution or 0.5-1mol/L Na 2hPO 4solution;
Extracting reagent is PEG solution, borate buffer solution etc. (adopting PEG method);
Glue bed medium is the one in sepharose, polyacrylamide gel;
The material purchase of catching IgE is the rabbit Anti-IgE antibody of Abcam ab171396 from the model of the prompt Science and Technology Ltd. of Amy; Wherein, material with IgE specific binding of the present invention, anti-IgE antibodies, IgE resist the material being and catching IgE;
The material purchase of catching arsenic is the mouse-anti As mAb of RK15728 from the model of Ran Ke bio tech ltd, Guangzhou; Wherein, of the present inventionly resist with the material of arsenic specific binding, anti-As antibody, anti-arsenic antibody, arsenic the material being and catching arsenic;
Enzyme labelled antibody is the one in the antibody containing the enzyme labelling such as horseradish peroxidase, alkaline phosphatase;
Substrate is methyl diphenyl amine (TMB) solution;
Washings is for containing KH 2pO 40.2mg/ml, Na 2hPO 412H 2the pH of O 2.90mg/ml, NaCl8.0mg/ml, KCl 0.2mg/ml, 0.5%Tween-20 is the 0.15M PBS solution of 7.4;
Confining liquid is 1%-5% bovine serum albumin or skim-milk;
Dilution buffer is for containing 1.5mg/mL Na 2cO 3, 2.93mg/ml NaHCO 3pH be 9.6 0.05M carbonate buffer solution;
Enzyme labelled antibody is HRP enzyme labelled antibody;
Stop buffer is: by the 2M H of 21.7ml 2sO 4be settled to the ddH of 200ml 2in O;
Elutriant be containing the PH of papoid be 8.0 0.1mol/L Tris-HCL damping fluid;
Souring agent is nitric acid;
Sample-loading buffer is for containing 1M Tris-HCl (pH 6.8) 15.5mL, 1% tetrabromophenol sulfonphthalein 2.5mL, ddH 2the Sample buffer (5X) of O7mL, glycine 25mL;
Electrophoretic buffer be containing Tris 3mg/ml, glycine 14.4mg/ml PH be the ddH of 6.8 2o solution.
The invention provides a kind of arsenic-IgE inner complex, arsonium ion and IgE by sulfydryl or/and cysteine residues chelating forms.
The present invention also provides a kind of preparation method of arsenic-IgE inner complex, comprises the following steps:
A) chelatropic reaction of arsenic and IgE: add arsonium ion and carry out chelatropic reaction in the IgE in people source, obtain reaction soln;
B) extraction of purifying arsenic-IgE inner complex: adopt immune-affinity chromatography, remove unreacted IgE and unnecessary arsonium ion in reaction soln, obtain arsenic-IgE inner complex, concrete steps are as follows:
(1) sample dissolution: to through steps A) add physiological saline in the reaction soln that obtains arsenic-IgE inner complex is redissolved;
(2) balance chromatography column: use dilution buffer to rinse the pipeline of chromatography column, load in chromatography column can with the filler of IgE specific binding, after dress post, continue to use dilution buffer balance chromatography column; Described can be the silica gel or the resin that contain anti-IgE antibodies with the filler of IgE specific binding;
(3) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (1), IgE and filler specific binding;
(4) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.05-0.1mol/L to carry out wash-out, obtain elutriant I;
(5) collect: collect elutriant I;
(6) dialyse: by the elutriant of the collection in step (5), dress dialysis tubing, uses ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample;
(7) balance chromatography column: adopt new chromatography column, use dilution buffer flushing pipeline, in this chromatography column load can with the filler of arsenic specific binding, dress post after balance chromatography column by dilution buffer again; Described can be the silica gel or the resin that contain anti-arsenic antibody with the filler of arsenic specific binding;
(8) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (6);
(9) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.5-1.0mol/L to carry out wash-out, obtain elutriant II;
(10) collect: collect elutriant II;
(11) dialyse: by the elutriant of the collection in step (10), dress dialysis tubing, with 2 liters of ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample, obtain arsenic-IgE inner complex;
C) to the qualification of arsenic-IgE inner complex, concrete steps are as follows:
(1) glue bed is prepared: prepare glue bed using the one in sepharose, polyacrylamide gel as medium;
(2) application of sample: get step B) in the arsenic-IgE inner complex that obtains of extraction purification, add dilution buffer, and mix, then application of sample is in sample cell;
(3) electrophoresis: connect electrophoresis plate, carry out electrophoresis;
(4) detect: on glue bed, find out the protein band containing arsenic, this protein band is taken out and dissolves, and then adopt ELISA method or ICP-MS method or AAS method to detect the content whether containing arsenic and detection arsenic.
The present invention also provides a kind of and at least comprises the test kit of arsenic-IgE inner complex described above as standard substance.
Preferably, also comprise coating buffer in this test kit, this coating buffer contains the material of catching IgE or the material of catching arsenic.
In the present invention, the test kit that can realize the object of the invention can be listed following several, but is not limited to this.
Detect a test kit for arsenic-IgE inner complex in blood sample, comprise the coating buffer containing the material of catching IgE, confining liquid, washings, material, enzyme labelled antibody, substrate, stop buffer, dilution buffer, positive control, negative control etc. as two anti-caught arsenic.
Detect a test kit for arsenic-IgE inner complex in blood sample, comprise the coating buffer containing the material of catching IgE, confining liquid, washings, elutriant, positive control, negative control etc.
Detect a test kit for arsenic-IgE inner complex in blood sample, comprise the coating buffer containing the material of catching IgE, confining liquid, washings, elutriant, souring agent, hydrogen peroxide, positive control, negative control etc.
Detect a test kit for arsenic-IgE inner complex in blood sample, comprise as extracting reagent in purification whole blood needed for IgE, redissolve liquid, containing the coating buffer, confining liquid, washings, enzyme labelled antibody, substrate, stop buffer, dilution buffer, positive control, negative control etc. of material of catching arsenic.
Detecting a test kit for arsenic-IgE inner complex in blood sample, comprising as extracting reagent, redissolution liquid, positive control, negative control etc. in purification whole blood needed for IgE.
Detecting a test kit for arsenic-IgE inner complex in blood sample, comprising as extracting reagent, redissolution liquid, souring agent, hydrogen peroxide, positive control, negative control etc. in purification whole blood needed for IgE.
Detect a test kit for arsenic-IgE inner complex in blood sample, comprise as extracting reagent, glue bed medium in purification whole blood needed for IgE, redissolve liquid, sample-loading buffer, on dissolving glue bed containing liquid needed for the protein band of arsenic, containing the coating buffer, confining liquid, washings, enzyme labelled antibody, substrate, stop buffer, dilution buffer, positive control, negative control etc. of material of catching arsenic.
Detect a test kit for arsenic-IgE inner complex in blood sample, comprise as extracting reagent, glue bed medium in purification whole blood needed for IgE, redissolve liquid, sample-loading buffer, on dissolving glue bed containing liquid, positive control, negative control etc. needed for the protein band of arsenic.
Detect a test kit for arsenic-IgE inner complex in blood sample, comprise as extracting reagent, glue bed medium in purification whole blood needed for IgE, redissolve liquid, sample-loading buffer, on dissolving glue bed containing liquid, souring agent, hydrogen peroxide, positive control, negative control etc. needed for the protein band of arsenic.
In above-mentioned several test kit, described positive control is standard substance, is namely chelated with the IgE inner complex of heavy arsenic or is chelated with the BSA inner complex of heavy arsenic; Described negative control is the dilution buffer not containing standard substance.
Mentioned reagent box is for detecting the IgE of chelating arsenic, to improve the accuracy of detection, repeated, and makes it to be promoted in clinical.
The present invention also provides a kind of method of detection by quantitative arsenic-IgE inner complex, using the above-mentioned arsenic-IgE inner complex of known content as standard substance, a pair sample of following methods is adopted to detect: euzymelinked immunosorbent assay (ELISA), enzyme linked immunological and atomic absorption spectrum combined techniques, enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques, purification arsenic-IgE inner complex and enzyme linked immunological combined techniques, purification arsenic-IgE inner complex and atomic absorption spectrum combined techniques, purification arsenic-IgE inner complex and inductivity coupled plasma mass spectrometry combined techniques, electrophoresis and enzyme linked immunological or atomic absorption spectrum or inductivity coupled plasma mass spectrometry combined techniques.In the present invention, following several with having of can listing of the method detecting arsenic-IgE inner complex, but be not limited to following several.
Wherein, the reagent adopted in the method for above-mentioned detection by quantitative arsenic-IgE inner complex is as follows:
method one:euzymelinked immunosorbent assay (ELISA) (ELISA method) detects arsenic-IgE inner complex, detects in accordance with the following steps:
1) material of IgE can be caught, as anti-IgE antibodies (anti-IgE Ab) is coated on solid phase carrier: with sample diluting liquid, anti-IgE Ab is diluted to 1000-8000 doubly, adds in elisa plate micropore, 4 DEG C of 16-18 hour that spend the night, or 37 DEG C of water-bath 1-3 hour, store refrigerator;
2) get whole blood from the recycle system, make measuring samples, the centrifugal 5-8 minute of 1000rmp, centrifugally discard precipitation;
3) close: remove sample diluting liquid, and wash with washings, after washing completes, add using 1%-5% bovine serum albumin or skim-milk as confining liquid, place 1 hour, remove confining liquid, and wash with washings for 37 DEG C, after having washed, elisa plate places 1-2 hour in 36.5-37.5 DEG C;
4) add measuring samples, and incubation: add step 2) in measuring samples, make standard substance with the arsenic-IgE inner complex of known content; By dilution buffer, measuring samples is diluted to 10-40 doubly, adds in micropore, 37 DEG C of effect 1-2 hour;
5) material can catching arsenic is added, and incubation: remove measuring samples, and wash with washings, after washing completes, add and be diluted to 25000-200000 anti-As Ab doubly by dilution buffer, 37 DEG C of effect 1-2 hour, make the arsenic reaction on anti-As Ab and IgE form immune complex;
6) enzyme conjugates incubation: remove anti-arsenic antibody, and wash with washings, after washing completes, add the enzyme labelled antibody with dilution buffer dilution, make the concentration of the enzyme labelled antibody of dilution be 2 μ g/mL, 37 DEG C of effect 1-2 hour, make itself and enzyme labelled antibody react;
7) substrate incubation: remove enzyme labelled antibody, and wash with washings, after washing completes, adds substrate, 37 DEG C of lucifuge effects 30 minutes;
8) termination reaction: stop buffer is dropped to each micropore;
9) wavelength 405nm is got, after adding stop buffer, elisa plate is placed in microplate reader and detects, read the OD value of measuring samples and standard substance respectively, by drawing standard curve, try to achieve the content (also microplate reader can not be used, directly carry out qualitative detection by colour developing situation) of measuring samples.
The method utilizes ELISA principle, specific IgE in whole blood can be extracted, the IgE upper part extracted is chelated with heavy arsenic, and the arsenic on this part IgE catch by anti-arsenic antibody, afterwards can again by horseradish peroxidase, the antibody of the enzyme labellings such as alkaline phosphatase is caught (this antibody nonrecognition coating protein), the antibody of catching is under the effect of developer and stop buffer, OD value can be read under instrument, and the IgE not containing chelating arsenic, then can not catch by the specific antibody of anti-arsenic, also can not with horseradish peroxidase, the antibody of the enzyme labellings such as alkaline phosphatase caught, and also not containing arsenic (negative control group result is negative) in agents useful for same, thus when read OD value result is shown as the positive, the i.e. provable arsenic detecting chelating on IgE.
method two:enzyme linked immunological and atomic absorption spectrum combined techniques (ELISA method+AAS method) detect arsenic-IgE inner complex and detect in accordance with the following steps:
1) material of IgE can be caught, as anti-IgE antibodies (anti-IgE Ab) is coated on solid phase carrier: with sample diluting liquid, anti-IgE Ab is diluted to 1000-8000 doubly, adds in elisa plate micropore, 4 DEG C of 16-18 hour that spend the night, or 37 DEG C of water-bath 1-3 hour, store refrigerator;
2) get whole blood from the recycle system, make measuring samples, the centrifugal 5-8 minute of 1000rmp, centrifugally discard precipitation;
3) close: remove sample diluting liquid, and wash with washings, after washing completes, add using 1%-5% bovine serum albumin or skim-milk as confining liquid, place 1 hour, remove confining liquid, and wash with washings for 37 DEG C, after having washed, elisa plate places 1-2 hour in 36.5-37.5 DEG C;
4) add measuring samples, and incubation: add step 2) in measuring samples, make standard substance with the arsenic-IgE inner complex of known content; By dilution buffer, measuring samples is diluted to 10-40 doubly, adds in micropore, 37 DEG C of effect 1-2 hour;
5) wash-out: remove measuring samples, and wash with washings, after washing completes, add elutriant, wash-out 1-3 hour at 37 DEG C.
6) detect: sample from the micropore of elisa plate, detect the arsenic of chelating on IgE in Atomic Absorption Spectroscopy AAS, and drawing standard curve, readout value;
In conjunction with atomic absorption spectrum (AAS) principle on the basis that the method utilizes ELISA principle, Atomic Absorption Spectroscopy AAS is utilized to detect the arsenic of chelating on IgE, owing to only containing IgE in solution, and not containing any arsenic (negative control group result is negative) in agents useful for same, interference can not be caused to result, thus when read result is shown as the positive, i.e. the provable arsenic detecting chelating on IgE.
method three:enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques (ELISA method+ICP-MS method) detect arsenic-IgE inner complex and detect in accordance with the following steps:
1) material of IgE can be caught, as anti-IgE antibodies (anti-IgE Ab) is coated on solid phase carrier: with sample diluting liquid, anti-IgE Ab is diluted to 1000-8000 doubly, adds in elisa plate micropore, 4 DEG C of 16-18 hour that spend the night, or 37 DEG C of water-bath 1-3 hour, store refrigerator;
2) get whole blood from the recycle system, make measuring samples, the centrifugal 5-8 minute of 1000rmp, centrifugally discard precipitation;
3) close: remove sample diluting liquid, and wash with washings, after washing completes, add using 1%-5% bovine serum albumin or skim-milk as confining liquid, place 1 hour, remove confining liquid, and wash with washings for 37 DEG C, after having washed, elisa plate places 1-2 hour in 36.5-37.5 DEG C;
4) add measuring samples, and incubation: add step 2) in measuring samples, make standard substance with the arsenic-IgE inner complex of known content; By dilution buffer, measuring samples is diluted to 10-40 doubly, adds in micropore, 37 DEG C of effect 1-2 hour;
5) wash-out: remove measuring samples, and wash with washings, after washing completes, add elutriant, wash-out 1-3 hour at 37 DEG C.
6) acidifying: in step 5) in solution in add souring agent acidifying carried out to solution, sealing is spent the night, and thorough acidifying, adds hydrogen peroxide, and acid is caught up with in heating;
7) detect: from step 6) elisa plate solution get 0.5ml liquid, under icp ms, detect chelating in the arsenic of IgE, and drawing standard curve, readout value.
The method is on the basis utilizing ELISA principle, in conjunction with sense coupled plasma mass spectrometry (ICP-MS) principle, the arsenic of chelating on IgE is detected with icp ms, owing to only containing IgE in solution, and not containing any arsenic (negative control group result is negative) in agents useful for same, interference can not be caused to result, thus when read result is shown as the positive, i.e. the provable arsenic detecting chelating on IgE.
method four:purification arsenic-IgE inner complex and enzyme linked immunological combined techniques (method of purification+ELISA method) detect arsenic-IgE inner complex, detect in accordance with the following steps:
1) from whole blood, IgE is extracted: adopt the polyoxyethylene glycol PEG precipitator method or ultracentrifugation or the method such as molecule ultrafiltration or gel-filtration from the IgE whole blood extraction purification blood, and redissolve in solution by IgE, obtain IgE solution;
2) anti-As Ab is coated on solid phase carrier: with sample diluting liquid, anti-As Ab is diluted to 25000-200000 doubly, adds in elisa plate micropore, 4 DEG C of 16-18 hour that spend the night, or 37 DEG C of water-bath 1-3 hour, store refrigerator;
3) close: remove sample diluting liquid, and wash with washings, after washing completes, add using 1%-5% bovine serum albumin or skim-milk as confining liquid, place 1 hour, remove confining liquid, and wash with washings for 37 DEG C, after having washed, elisa plate places 1-2 hour in 36.5-37.5 DEG C;
4) add measuring samples, and incubation: from step 1) solution sample, make measuring samples; Standard substance are made with the arsenic-IgE inner complex of known content; By dilution buffer, measuring samples is diluted to 10-40 doubly, adds in micropore, 37 DEG C of effect 1-2 hour;
5) enzyme conjugates incubation: remove step 4) in measuring samples, and to wash with washings, after washing completes, add the enzyme labelled antibody with dilution buffer dilution, make the concentration of the enzyme labelled antibody of dilution be 2 μ g/mL, 37 DEG C of effect 1-2 hour, make itself and enzyme labelled antibody react;
6) substrate incubation: remove enzyme labelled antibody, and wash with washings, after washing completes, adds substrate, 37 DEG C of lucifuge effects 30 minutes;
7) termination reaction: stop buffer is dropped to each micropore;
8) wavelength 405nm is got, after adding stop buffer, elisa plate is placed in microplate reader and detects, read the OD value of measuring samples and standard substance respectively, by drawing standard curve, try to achieve the content (also microplate reader can not be used, directly carry out qualitative detection by colour developing situation) of measuring samples.
method five:purification arsenic-IgE inner complex and atomic absorption spectrum combined techniques (method of purification+AAS method) detect arsenic-IgE inner complex in blood sample, detect in accordance with the following steps:
1) from whole blood, IgE is extracted: adopt the polyoxyethylene glycol PEG precipitator method or ultracentrifugation or the method such as molecule ultrafiltration or gel-filtration from the IgE whole blood extraction purification blood, and redissolve in solution by IgE, obtain IgE solution;
2) detect: from step 1) sample the solution that obtains, detect the arsenic of chelating on IgE in Atomic Absorption Spectroscopy AAS, and drawing standard curve, readout value.
method six:purification arsenic-IgE inner complex and inductivity coupled plasma mass spectrometry combined techniques (method of purification+ICP-MS method) detect arsenic-IgE inner complex, detect in accordance with the following steps:
1) from whole blood, IgE is extracted: adopt the polyoxyethylene glycol PEG precipitator method or ultracentrifugation or the method such as molecule ultrafiltration or gel-filtration from the IgE whole blood extraction purification blood, and redissolve in solution by IgE, obtain IgE solution;
2) acidifying: from step 1) sample the solution that obtains, add souring agent (as nitric acid) in the solution and carry out acidifying to solution, sealing is spent the night, and thorough acidifying, adds hydrogen peroxide, and acid is caught up with in heating;
3) detect: from step 2) get 0.5ml liquid the solution that obtains, under icp ms, detect the arsenic of chelating on IgE, and drawing standard curve, readout value.
method seven:electrophoresis and euzymelinked immunosorbent assay (ELISA) or atomic absorption spectrometry or inductivity coupled plasma mass spectrometry combined techniques (electrophoretic method-ELISA method/AAS method/ICP-MS method) detect arsenic-IgE inner complex, detect in accordance with the following steps:
1) from whole blood, IgE is extracted: adopt the polyoxyethylene glycol PEG precipitator method or ultracentrifugation or the method such as molecule ultrafiltration or gel-filtration from the IgE whole blood extraction purification blood, and redissolve in solution by IgE, obtain IgE solution;
2) glue bed is prepared: select sepharose or polyacrylamide gel or SDS-polyacrylamide gel etc. as medium as required, conventionally prepare glue bed;
3) application of sample: get step 1) the solution 8 μ L that obtains adds 2 μ L sample-loading buffers, mixing, of short duration centrifugal; (noticing that step can not be boiled herein)
4) electrophoresis: connect electrophoresis plate, carry out electrophoretic separation;
5) detect: on glue bed, find out the protein band containing arsenic, this band is taken out, this protein band is dissolved among liquid, and then utilize ELISA or ICP-MS or AAS to detect the arsenic content be dissolved in liquid respectively.In addition, the iso-electric point of the IgE of this method detection chelating arsenic, molecular weight and content etc. can also be utilized.
IgE in method seven can with multiple Methods For Purification out (such as ultracentrifugation or HPLC or gel-filtration chromatography or gel electrophoresis or ELISA method etc.), the IgE purified out is redissolved in solution, get a certain amount of IgE, utilize electric charge shifting principle, carry out electrophoresis (electrophoresis, EP), can according to molecular weight on gel slab (different media can be adopted as required), the difference such as iso-electric point runs out of different bands, find out the respective strap being rich in arsenic, protein in gel is redissolved in solution, namely the content of relevant IgE can be detected at a particular wavelength, also ELISA can be utilized, AAS, the principles such as ICP-MS detect the arsenic content of chelating on IgE, owing to only containing IgE in solution, and not containing any arsenic (negative control group result is negative) in agents useful for same, interference can not be caused to result, thus when read result is shown as the positive, the i.e. provable arsenic detecting chelating on IgE.
embodiment 1: the preparation method of arsenic-IgE inner complex, comprises the following steps:
A) chelatropic reaction of arsenic and IgE: add arsonium ion and carry out chelatropic reaction in the IgE in people source, obtain reaction soln;
Preparation of reagents:
1) borate buffer solution (0.01M): take 0.31g boric acid and be dissolved in 400ml ultrapure water, regulates pH to 9.0 with the NaOH of 0.1M, is settled to 500mL.
2) IgE solution: take 4.0mg IgE and be dissolved in 4.0mL 0.01M pH9.0 borate buffer solution, dissolving of fully vibrating, is mixed with the protein solution of 1.0mg/mL;
3) EDTA-NaHCO3 mixing solutions: take EDTA2H 2o 1.86g, NaHCO 316.8g is dissolved in 900mL ultrapure water, adjusts pH to 8.0 be settled to 1000ml, autoclaving, room temperature preservation with 1.0M NaOH;
4) ITCBE buys from Japanese colleague's chemistry institute, and article No. is M030;
5) dialysis tubing is purchased from Bioshop Inc, molecular weight cut-off 14000.
The chelation step of arsenic-IgE inner complex:
1) process of dialysis tubing: EDTA-NaHCO dialysis tubing being put into 500ml 3in mixing solutions, boil 10min; Tipping EDTA/NaHCO 3liquid, with ultrapure water rinsing gently, then boils 10min with the 5mmol/LEDTA solution of 500ml; Discard boiling liquid, thoroughly clean with ultrapure water, add ultrapure water immersion dialysis tubing 4 DEG C and spend the night.During use, put on one's gloves, take out dialysis tubing, with its surfaces externally and internally of ultrapure water cleaning down;
2) getting 2.0mg ITCBE is dissolved in 2ml DMSO;
3) getting 4.0mg IgE is dissolved in 4.0ml borate buffer solution;
4) slowly by step 2) liquid prepared adds step 3) in the IgE solution prepared, dropping limit, limit is shaken, and being placed in temperature is 25 DEG C, and rotating speed is react 24h in the shaking table of 100r/min, then to dialyse 24h with dialysis tubing, remove the ITCBE be not combined with IgE;
5) by step 4) the liquid 1mol/L HCl adjust ph to 7.0 of gained, then slowly drip the 1mmol/L arsenic ion soln of 80 μ l gradually, dropping limit, limit vibrates, in order to avoid arsonium ion makes protein denaturation precipitate;
6) by step 5) to be placed in temperature be 25 DEG C for the solution of gained, rotating speed is react 2h in the shaking table of 100r/min, carries out dialysis 24h with dialysis tubing;
7) by step 6) dialysis after liquid preserve in-20 DEG C of packing, obtain reaction soln.B) extraction of purifying arsenic-IgE inner complex: adopt immune-affinity chromatography, removes reaction soln (the i.e. step 7) reaction soln that obtains) in unreacted IgE and unnecessary arsonium ion, obtain arsenic-IgE inner complex, concrete steps are as follows:
(1) sample dissolution: to through step 7) add physiological saline in the reaction soln that obtains arsenic-IgE inner complex is redissolved;
(2) balance chromatography column: use dilution buffer to rinse the pipeline of chromatography column, load in chromatography column can with the filler of IgE specific binding, after dress post, continue to use dilution buffer balance chromatography column;
(3) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (1), IgE and filler specific binding;
(4) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.05-0.1mol/L to carry out wash-out, obtain elutriant I;
(5) collect: collect elutriant I;
(6) dialyse: by the elutriant of the collection in step (5), dress dialysis tubing, uses ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample;
(7) balance chromatography column: adopt new chromatography column, use dilution buffer flushing pipeline, in this chromatography column load can with the filler of arsenic specific binding, dress post after balance chromatography column by dilution buffer again;
(8) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (6);
(9) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.5-1.0mol/L to carry out wash-out, obtain elutriant II;
(10) collect: collect elutriant II;
(11) dialyse: by the elutriant of the collection in step (10), dress dialysis tubing, with 2 liters of ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample, obtain arsenic-IgE inner complex;
C) to the qualification of arsenic-IgE inner complex, concrete steps are as follows:
(1) glue bed is prepared: prepare glue bed using sepharose as medium;
(2) application of sample: get step B) in the arsenic-IgE inner complex that obtains of 8 μ L extraction purification, add 2 μ L sample-loading buffers, and mix, then application of sample is in sample cell;
(3) electrophoresis: connect electrophoresis plate, add electrophoretic buffer and carry out electrophoresis; In electrophoresis process, electric current is 22mA constant current, and envrionment temperature is 4 DEG C; Electrophoresis is stopped when electrophoresis to tetrabromophenol sulfonphthalein moves to bottom glue;
(4) detect: on glue bed, find out the protein band containing arsenic, this protein band is taken out and dissolves, and then adopt ELISA method or ICP-MS method or AAS method to detect the content whether containing arsenic and detection arsenic.
D) detected result
(1) arsenic content in graphite furnace atomic absorption spectrometry (AAS) rough determination IgE: the results are shown in Table 1
Table 1 is arsenic content in IgE (μ g/L)
Sample name As(μg/L)
IgE 179.668
(NH 4) 2SO 4 0.077
N.S 0
N.S 0.014
(2) electrophoresis result:
Wherein, Fig. 1 is the non denatured electrophoretic band figure of arsenic-IgE inner complex of the present invention.
Native polyacrylamide gel electrophoresis (Native-PAGE) or be called that active electrophoresis is under the condition not adding the denaturing agent such as SDS and thin base ethanol, to keeping active protein to carry out polyacrylamide gel electrophoresis, be usually used in the qualification of enzyme, Isozyme Analysis and purification.The native polyacrylamide gel electrophoresis not adding SDS can make biomacromolecule in electrophoresis process, keep its natural shape and electric charge, their separation is the molecular sieve effect of difference according to its electrophoretic mobility and gel, thus higher resolving power can be obtained, especially after electrophoretic separation, still can keep the biological activity of the biomacromolecule such as protein and enzyme, therefore the right swimming lane M is sex change Marker, only for detecting, do not mark effect, swimming lane 4 is the band of IgE.
(3) Synchrotron Radiation X-Ray Fluorescence Anal ysis:
In protein band, the SRXRF of micronutrient levels analyzes and " synchrotron radiation bunch completes at the 4W1 of Beijing electron positron collider (BEPC).In storage ring, beam current energy is 2.2GeV, beam intensity 100mA.Sample transfer table (TSA200 type, Beijing stand upright Han Guang company) can move up to change launching spot position along X, Y two-dimensional square under computer-controlled step motor drives, and moving step length is 0.0025mm.The X-ray gone out from electromagnetic radiation is detected by Si (Li) detector (PGT Inc.LS 30143-DS), probe is mutually vertical with incident SR line copline, apart from sample irradiation point 20mm, signal obtains with PGT MCA (MCA4000) and exports.By the monochromatic synchrotron radiation light excited sample of 11.5keV, launching spot (1mmx3mm) position is regulated to make it to be in band one end, in the minute of 300s, hot spot is always along band evenly slowly movement, and at the end of counting, hot spot moves on to this band the other end.A spectrum is got along the every 1mm in electrophoresis direction.Adopt AX IL software data processing, and with deriving from air and the Ar fignal center of content constant carries out normalization to other element peak, to offset the impact that beam intensity change produces signal power.Measure the fluorescence Spectra of the dry glued membrane of quantitative criterion at identical conditions in the same way.
Fig. 2 is the synchrotron radiation X line fluorometric analysis figure of the electrophoretic band of arsenic-IgE inner complex of the present invention, and in figure, X-coordinate is protein band position, and ordinate zou is energy (content) value of this band arsenic.
the determination of the testing conditions of the method for a kind of detection by quantitative arsenic of the present invention-IgE inner complex:
1. the determination of the optimum diluting multiple of anti-IgE antibodies, anti-arsenic antibody best effort concentration and blood plasma
Step is as follows:
(1) be that 1:1000,1:2000,1:4000,1:8000 dilute by anti-IgE Ab dilution buffer according to the mass volume ratio of anti-IgE Ab and dilution buffer, add in elisa plate micropore, anti-IgEAb is coated on solid phase carrier, each concentration bag is by three rows, and 4 DEG C are spent the night 18 hours;
(2) remove sample diluting liquid, and wash with washings, after washing completes, with 2% bovine serum albumin as confining liquid, place 1 hour, remove confining liquid, and wash with washings for 37 DEG C;
(3) measuring samples is that 1:10,1:20,1:40 dilute by the mass volume ratio of measuring samples and dilution buffer, add in micropore, according to the anti-IgE Ab concentration of above-mentioned bag quilt, the anti-IgE Ab of same concentration adds different extent of dilution blood plasma respectively, 37 DEG C of effects 1 hour;
(4) measuring samples is removed, and wash with washings, after washing completes, add anti-As Ab, anti-As Ab is that 1:25000,1:50000,1:100000,1:200000 dilute by the mass volume ratio of anti-As Ab and dilution buffer, and according to each identical anti-IgE Ab, serum-dilution concentration, the anti-As Ab of different concns respectively adds 2 holes, 37 DEG C act on 1 hour, the arsenic on anti-As Ab and IgE are reacted;
(5) enzyme labelled antibody selects the suitableeest working concentration, i.e. 2 μ g/mL, removes anti-As antibody, and wash with washings, after washing completes, add with dilution buffer dilution HRP enzyme labelled antibody, 37 DEG C act on 1 hour, HRP enzyme labelled antibody and arsenic-IgE inner complex are reacted;
(6) remove enzyme labelled antibody, and wash with washings, after washing completes, add substrate, 37 DEG C of lucifuge effects 30 minutes;
(7) stop buffer is dropped to each micropore;
(8) get wavelength 405nm, after adding stop buffer, elisa plate is placed in microplate reader and detects, read each hole OD value respectively.According to each hole OD value numerical value, select anti-IgE Ab, the best effort concentration of anti-As Ab and the optimum diluting multiple of blood plasma.
Simultaneously using made standard substance as positive control in test, select anti-IgE Ab+ close+anti-As Ab+ enzyme mark+substrate (namely not adding measuring samples) is as negative control 1; Anti-IgE Ab+ closes+and blood plasma+enzyme mark+substrate (namely not adding anti-As Ab) is as negative control 2; Anti-IgE Ab+ closes+and enzyme mark+substrate (namely not adding measuring samples and anti-As Ab) is as negative control 3; Anti-IgE Ab+ closes+and blood plasma+anti-As Ab+ substrate (i.e. not enzyme-added mark) is as negative control 4; Closed+blood plasma+anti-As Ab+ enzyme mark+substrate (namely do not add anti-IgE Ab and catch IgE) is as blank 1; Only add substrate as blank 2 and PBS as blank 3.Detected result is in Table 2-3.
Table 2: Checkerboard titration method determines the data (each data are all mean value) of anti-IgE Ab, the best effort concentration of anti-As Ab and the optimum diluting multiple of blood plasma
Table 3:ELISA positive control and negative control ELISA detected result
By table 2-3 data presentation, when we can find out, and the extent of dilution when anti-IgE antibodies is 1:2000, dilution rate of blood plasma be the anti-extent of dilution of 1:20, As is 1:25000, OD value is maximum, so select concentration corresponding to this value as best effort concentration.
2. the determination of elutriant best effort concentration and elution time in method two, three in the method for detection by quantitative arsenic-IgE inner complex
Step is as follows: (1) bag quilt: anti-As Ab dilution buffer be diluted to 25000 times (mass volume ratios), add in elisa plate micropore, 37 DEG C of water-baths 3 hours, stores refrigerator;
(2) close: remove sample diluting liquid, and wash with washings, after washing completes, with 2% bovine serum albumin as confining liquid, place 1 hour, remove confining liquid, and wash with washings for 37 DEG C;
(3) remove confining liquid, and wash with washings, after washing completes, add the enzyme labelled antibody with dilution buffer dilution, it is 2 μ g/mL that enzyme labelled antibody is diluted to concentration, and 37 DEG C act on 2 hours, itself and anti-As Ab are reacted;
(4) prepare elutriant: papoid pH 8.0,0.1mol/L Tris-HCI buffer is become 100ng/ml, then add 1mmol/L dithiothreitol (DTT) (DTT) 37 DEG C and hatch 30min;
(5) enzyme labelled antibody is removed, by dilution buffer, elutriant is diluted, make the concentration of the papoid in elutriant and the ratio of the concentration of enzyme labelled antibody be 1:80,1:40,1:20,1:10,1:5 (wherein each concentration does 3 multiple holes), be positioned over wash-out 1h, 2h, 3h at 37 DEG C of temperature respectively;
(6) remove elutriant, and wash with washings, after washing completes, add substrate, 37 DEG C of lucifuge effects 30 minutes;
(7) stop buffer is dropped to each micropore;
(8) get 405nm wavelength, after adding stop buffer, be placed in by elisa plate in microplate reader and detect, read respectively and often organize OD value, by comparing with PBS damping fluid group, compare optimal concentration and the elution time of elutriant, concrete outcome is see table 4.
Table 4:ELISA elutriant best effort concentration and elution time are determined
From table 4, we can find, as the ratio=1:20 of the concentration of the papoid in elutriant with the concentration of enzyme labelled antibody, each group of OD value is all lower than other several groups, this concentration elution effect optimum (reach maximum by the anti-As Ab-enzyme mark mixture wash-out degree that ELISA hole wall combines, thus OD value is minimum) is described; And no matter elution time is 1h, 2h, 3h, the change of each group OD value is all little, as seen along with the prolongation of time, enzyme activity weakens gradually, when enzyme concn is constant, extends digestion time and can not improve digestibility, so the elution time of elutriant is that 1-3h all can in this test.
application Example 1
Get and adopt ELISA method to detect arsenic-IgE inner complex in 100 parts of sample blood plasma, detect according to following steps: euzymelinked immunosorbent assay (ELISA) (ELISA method) detects arsenic-IgE inner complex, detect in accordance with the following steps:
1) anti-IgE Ab is coated on solid phase carrier: with sample diluting liquid, anti-IgE Ab is diluted to 2000 times, adds in elisa plate micropore, 37 DEG C of water-baths 1 hour, store refrigerator;
2) get whole blood from the recycle system, make measuring samples, the centrifugal 5-8 minute of 1000rmp, centrifugally discard precipitation;
3) close: remove sample diluting liquid, and wash with washings, after washing completes, add 2% bovine serum albumin as confining liquid, place 1 hour, remove confining liquid for 37 DEG C, and wash with washings, after having washed, elisa plate is placed 1 hour in 37 DEG C;
4) add measuring samples, and incubation: add step 2) in measuring samples, make standard substance with the arsenic-IgE inner complex of known content; By dilution buffer, measuring samples is diluted to 20 times, adds in micropore, 37 DEG C act on 1 hour;
5) material can catching arsenic is added, and incubation: remove measuring samples, and wash with washings, after washing completes, add and dilute 25000 times by dilution buffer, 37 DEG C act on 1 hour, the arsenic on anti-As Ab and IgE are reacted;
6) enzyme conjugates incubation: remove anti-arsenic antibody, and wash with washings, after washing completes, adds the HRP enzyme labelled antibody with dilution buffer dilution, and 37 DEG C act on 1 hour, itself and enzyme labelled antibody are reacted;
7) substrate incubation: remove enzyme labelled antibody, and wash with washings, after washing completes, adds substrate, 37 DEG C of lucifuge effects 30 minutes;
8) termination reaction: stop buffer is dropped to each micropore;
9) getting wavelength is 405nm, after adding stop buffer, is placed in by elisa plate in microplate reader and detects, and read measuring samples OD value (also can not use microplate reader, directly carry out qualitative detection by colour developing situation) respectively, concrete detected value is as shown in table 5.
The ELISA detected result of arsenic-IgE inner complex in table 5:100 part blood sample
Numbering 1 2 3 4 5 6 7 8 9 10
OD 405 0.751 0.402 0.443 0.615 0.433 0.26 0.401 0.84 0.794 0.634
Numbering 11 12 13 14 15 16 17 18 19 20
OD 405 0.391 0.5 0.763 0.207 0.114 0.421 0.721 0.694 0.643 0.856
Numbering 21 22 23 24 25 26 27 28 29 30
OD 405 0.761 0.708 0.653 0.56 0.118 0.614 0.544 0.402 0.639 0.657
Numbering 31 32 33 34 35 36 37 38 39 40
OD 405 0.148 0.895 0.68 0.5 0.614 0.57 0.801 0.167 0.833 0.188
Numbering 41 42 43 44 45 46 47 48 49 50
OD 405 0.529 0.76 0.391 0.277 0.157 0.208 0.336 0.808 0.663 0.729
Numbering 51 52 53 54 55 56 57 58 59 60
OD 405 0.695 0.527 0.612 0.811 0.391 0.734 0.155 0.172 0.774 0.743
Numbering 61 62 63 64 65 66 67 68 69 70
OD 405 0.161 0.354 0.353 0.245 0.869 0.817 0.563 0.23 0.795 0.293
Numbering 71 72 73 74 75 76 77 78 79 80
OD 405 0.13 0.144 0.847 0.432 0.475 0.122 0.907 0.238 0.411 0.709
Numbering 81 82 83 84 85 86 87 88 89 90
OD 405 0.859 0.697 0.808 0.846 0.301 0.235 0.694 0.815 0.331 0.247
Numbering 91 92 93 94 95 96 97 98 99 100
OD 405 0.21 0.697 0.624 0.775 0.246 0.238 0.305 0.881 0.166 0.246
application Example 2
Employing enzyme linked immunological and atomic absorption spectrum combined techniques (ELISA method+AAS method) detect the arsenic-IgE inner complex in 100 points of sample blood samples, detect in accordance with the following steps:
1) material of IgE can be caught, as anti-IgE antibodies (anti-IgE Ab) is coated on solid phase carrier: with sample diluting liquid, anti-IgE Ab is diluted to 2000 times, adds in elisa plate micropore, 4 DEG C are spent the night 18 hours;
2) get whole blood from the recycle system, make measuring samples, the centrifugal 5-8 minute of 1000rmp, centrifugally discard precipitation;
3) close: remove sample diluting liquid, and wash with washings, after washing completes, add 2% bovine serum albumin or skim-milk as confining liquid, place 1 hour, remove confining liquid for 37 DEG C, and wash with washings, after having washed, elisa plate is placed 1 hour in 37 DEG C;
4) add measuring samples, and incubation: add step 2) in measuring samples, make standard substance with the arsenic-IgE inner complex of known content; By dilution buffer, measuring samples is diluted to 20 times, adds in micropore, 37 DEG C act on 1 hour;
5) wash-out: remove measuring samples, and wash with washings, after washing completes, add the elutriant that Papain enzyme concn is 100ng/ml, wash-out 1-3 hour;
6) detect: sample from the micropore of elisa plate, detect the arsenic of chelating on IgE in Atomic Absorption Spectroscopy AAS, detected value is as shown in table 6.
The AAS detected result of arsenic-IgE inner complex in table 6:100 part blood sample
Numbering 1 2 3 4 5 6 7 8 9 10
μg/L 3.876 3.436 0.678 4.355 0.168 4.671 1.973 4.789 1.131 2.74
Numbering 11 12 13 14 15 16 17 18 19 20
μg/L 3.743 1.207 1.536 3.128 0.215 4.886 0.811 2.434 3.981 1.903
Numbering 21 22 23 24 25 26 27 28 29 30
μg/L 3.248 0.041 5.084 2.188 4.734 2.53 0.601 3.204 3.822 2.099
Numbering 31 32 33 34 35 36 37 38 39 40
μg/L 3.41 1.444 1.323 2.035 0.11 4.839 2.526 4.573 4.295 3.931
Numbering 41 42 43 44 45 46 47 48 49 50
μg/L 1.07 0.359 3.944 0.515 1.874 0.835 3.541 0.814 2.295 2.533
Numbering 51 52 53 54 55 56 57 58 59 60
μg/L 3.629 0.231 2.497 4.673 4.654 1.449 2.489 2.215 5.213 3.68
Numbering 61 62 63 64 65 66 67 68 69 70
μg/L 3.442 3.077 3.271 3.716 2.271 1.148 2.446 0.467 1.685 0.446
Numbering 71 72 73 74 75 76 77 78 79 80
μg/L 5.236 1.352 3.694 0.378 4.382 0.861 4.462 5.022 1.068 0.729
Numbering 81 82 83 84 85 86 87 88 89 90
μg/L 4.901 4.721 3.405 3.934 0.375 0.41 4.819 1.81 2.205 0.247
Numbering 91 92 93 94 95 96 97 98 99 100
μg/L 1.141 0.577 2.145 2.783 0.135 4.867 4.058 2.37 1.354 1.345
application Example 3
Employing enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques (ELISA method+ICP-MS method) detect the arsenic-IgE chelate content in 100 points of sample blood samples, detect in accordance with the following steps:
1) material of IgE can be caught, as anti-IgE antibodies (anti-IgE Ab) is coated on solid phase carrier: with sample diluting liquid, anti-IgE Ab is diluted to 2000 times, adds in elisa plate micropore, 4 DEG C are spent the night 18 hours;
2) 100 parts of standard blood samples are got as measuring samples;
3) close: remove sample diluting liquid, and wash with washings, after washing completes, add 2% bovine serum albumin as confining liquid, place 1 hour, remove confining liquid for 37 DEG C, and wash with washings, after having washed, elisa plate is placed 1 hour in 37 DEG C;
4) add measuring samples, and incubation: add step 2) in measuring samples, make standard substance with the arsenic-IgE inner complex of known content; By dilution buffer, measuring samples is diluted to 20 times, adds in micropore, 37 DEG C act on 1 hour;
5) wash-out: remove measuring samples, and wash with washings, after washing completes, add the elutriant that Papain enzyme concn is 100ng/ml, wash-out 1-3 hour;
6) acidifying: in step 5) in solution in add nitric acid acidifying carried out to solution, sealing is spent the night, and thorough acidifying, adds hydrogen peroxide, and acid is caught up with in heating;
7) detect: from step 6) sample the solution that obtains, under icp ms, detect chelating in the arsenic of IgE, detected value is as shown in table 7.
The ICP-MS detected result of arsenic-IgE inner complex in table 7:100 part blood sample
Numbering 1 2 3 4 5 6 7 8 9 10
μg/L 1.226 3.411 1.862 3.27 3.215 1.726 4.342 4.364 1.923 3.489
Numbering 11 12 13 14 15 16 17 18 19 20
μg/L 2.831 3.927 4.755 2.706 1.491 2.876 4.719 2.933 5.234 0.916
Numbering 21 22 23 24 25 26 27 28 29 30
μg/L 3.733 1.154 3.657 4.378 0.156 0.701 4.525 0.867 4.296 2.421
Numbering 31 32 33 34 35 36 37 38 39 40
μg/L 5.174 1.334 0.437 0.542 1.539 2.388 3.844 4.721 3.327 4.263
Numbering 41 42 43 44 45 46 47 48 49 50
μg/L 4.833 1.805 1.209 2.774 2.544 1.882 0.993 1.494 0.309 0.567
Numbering 51 52 53 54 55 56 57 58 59 60
μg/L 4.725 4.167 0.401 1.175 1.516 5.223 0.367 0.669 2.843 0.212
Numbering 61 62 63 64 65 66 67 68 69 70
μg/L 2.012 4.702 1.957 4.176 3.601 3.705 2.9 4.496 1.557 4.075
Numbering 71 72 73 74 75 76 77 78 79 80
μg/L 4.709 2.396 1.549 3.829 2.595 0.163 2.914 0.768 1.555 5.085
Numbering 81 82 83 84 85 86 87 88 89 90
μg/L 3.892 1.115 3.182 4.197 5.177 4.587 2.612 4.916 3.771 2.026
Numbering 91 92 93 94 95 96 97 98 99 100
μg/L 1.342 4.765 1.629 5.196 2.012 2.229 1.618 1.886 2.175 4.452
To one skilled in the art, according to technical scheme described above and design, other various corresponding change and deformation can be made, and all these change and deformation all should belong within the protection domain of the claims in the present invention.

Claims (8)

1. an arsenic-IgE inner complex, is characterized in that, arsonium ion and IgE by sulfydryl or/and cysteine residues chelating forms.
2. a preparation method for arsenic-IgE inner complex as claimed in claim 1, is characterized in that, comprise the following steps:
A) chelatropic reaction of arsenic and IgE: add arsonium ion in the IgE coming from human body or the IgE recombinated according to biological method and carry out chelatropic reaction purifying, obtain reaction soln;
B) extraction of purifying arsenic-IgE inner complex: adopt immune-affinity chromatography, removes unreacted IgE and unnecessary arsonium ion in reaction soln, obtains arsenic-IgE inner complex.
3. preparation method according to claim 2, is characterized in that,
Described step B) specific as follows:
(1) sample dissolution: to through steps A) add physiological saline in the reaction soln that obtains arsenic-IgE inner complex is redissolved;
(2) balance chromatography column: use dilution buffer to rinse the pipeline of chromatography column, load in chromatography column can with the filler of IgE specific binding, after dress post, continue to use dilution buffer balance chromatography column;
(3) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (1), IgE and filler specific binding;
(4) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.05-0.1mol/L to carry out wash-out;
(5) collect: collect elutriant I;
(6) dialyse: by the elutriant of the collection in step (5), dress dialysis tubing, uses ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample;
(7) balance chromatography column: adopt new chromatography column, use dilution buffer flushing pipeline, in this chromatography column load can with the filler of arsenic specific binding, dress post after balance chromatography column by dilution buffer again;
(8) loading: after chromatography column balance, with sample, then upper prop in dilution buffer dilution step (6);
(9) wash-out: use dilution buffer to rinse chromatography column and balance to baseline, then use the phosphate solution of 0.5-1.0mol/L to carry out wash-out;
(10) collect: collect elutriant II;
(11) dialyse: by the elutriant of the collection in step (10), dress dialysis tubing, uses ddH 2o dialyses desalination, and after changing water three times, 4 DEG C of dialysed overnight, collect sample, obtain arsenic-IgE inner complex.
4. the preparation method of arsenic-IgE inner complex according to claim 2, is characterized in that, also comprise step C): to the qualification of arsenic-IgE inner complex;
Wherein, step C) in specific as follows:
(1) glue bed is prepared: prepare glue bed using the one in sepharose, polyacrylamide gel as medium;
(2) application of sample: get step B) in the arsenic-IgE inner complex that obtains of extraction purification, add dilution buffer, and mix, then application of sample is in sample cell;
(3) electrophoresis: connect electrophoresis plate, carry out electrophoresis;
(4) detect: on glue bed, find out the protein band containing arsenic, this protein band is taken out and dissolves, and then adopt ELISA method or ICP-MS method or AAS method to detect the content whether containing arsenic and detection arsenic.
5. the application of arsenic-IgE inner complex as claimed in claim 1 in the reagent or test kit preparing to detect arsenic-IgE inner complex in blood sample.
6. one kind at least comprises the test kit of arsenic-IgE inner complex as claimed in claim 1 as standard substance.
7. test kit according to claim 6, is characterized in that, also comprises coating buffer, and this coating buffer contains the material of catching IgE or the material of catching arsenic.
8. the method for a detection by quantitative arsenic-IgE inner complex, it is characterized in that, using the arsenic-IgE inner complex according to claim 1 of known content as standard substance, a pair sample of following methods is adopted to detect: euzymelinked immunosorbent assay (ELISA), enzyme linked immunological and atomic absorption spectrum combined techniques, enzyme linked immunological and inductivity coupled plasma mass spectrometry combined techniques, purification arsenic-IgE inner complex and enzyme linked immunological combined techniques, purification arsenic-IgE inner complex and atomic absorption spectrum combined techniques, purification arsenic-IgE inner complex and inductivity coupled plasma mass spectrometry combined techniques, electrophoresis and enzyme linked immunological or atomic absorption spectrum or inductivity coupled plasma mass spectrometry combined techniques.
CN201510413294.5A 2015-07-14 2015-07-14 Arsenic-IgE chelate as well as preparation method and application thereof Pending CN104987412A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510413294.5A CN104987412A (en) 2015-07-14 2015-07-14 Arsenic-IgE chelate as well as preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510413294.5A CN104987412A (en) 2015-07-14 2015-07-14 Arsenic-IgE chelate as well as preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN104987412A true CN104987412A (en) 2015-10-21

Family

ID=54299327

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510413294.5A Pending CN104987412A (en) 2015-07-14 2015-07-14 Arsenic-IgE chelate as well as preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN104987412A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11214627B2 (en) 2016-06-10 2022-01-04 UCB Biopharma SRL Anti-IgE antibodies
RU2816207C2 (en) * 2016-06-10 2024-03-27 Юсб Биофарма Срл Anti-ige antibodies

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022490A1 (en) * 1993-03-29 1994-10-13 Immunomedics, Inc. Conjugates of proteins and bifunctional ligands

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022490A1 (en) * 1993-03-29 1994-10-13 Immunomedics, Inc. Conjugates of proteins and bifunctional ligands

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朱万森: "《生命中的化学元素》", 31 December 2014 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11214627B2 (en) 2016-06-10 2022-01-04 UCB Biopharma SRL Anti-IgE antibodies
RU2816207C2 (en) * 2016-06-10 2024-03-27 Юсб Биофарма Срл Anti-ige antibodies
US12054559B2 (en) 2016-06-10 2024-08-06 UCB Biopharma SRL Anti-IgE antibodies

Similar Documents

Publication Publication Date Title
CN104987412A (en) Arsenic-IgE chelate as well as preparation method and application thereof
CN105137059B (en) Mercury chelating immune complex and preparation method and application thereof
CN105004684A (en) Nickel-IgE chelate as well as preparation method and application thereof
CN104987411A (en) Cadmium-IgA chelate as well as preparation method and application thereof
CN104987413A (en) Arsenic-IgA chelate as well as preparation method and application thereof
CN104987410A (en) Lead-IgE chelate as well as preparation method and application thereof
CN104987409B (en) lead-IgG chelate as well as preparation method and application thereof
CN105037537A (en) lead-IgA chelate as well as preparation method and application thereof
CN104987400A (en) Mercury-hemoglobin chelate as well as preparation method and application thereof
CN105021548B (en) Arsenic-fibrinogen chelate as well as preparation method and application thereof
CN104987406A (en) Nickel-IgA chelate as well as preparation method and application thereof
CN105001321A (en) Mercury-fibrinogen chelate and preparation method and application thereof
CN104987408A (en) Mercury-IgA chelate as well as preparation method and application thereof
CN105037536A (en) cadmium-IgE chelate as well as preparation method and application thereof
CN105004685B (en) Mercury-IgE chelate and preparation method and application thereof
CN105044005B (en) chromium-IgA chelate as well as preparation method and application thereof
CN105153299A (en) lead-IgM chelate as well as preparation method and application thereof
CN105044004B (en) Mercury-IgM chelate as well as preparation method and application thereof
CN104987390A (en) Cadmium-albumin chelate as well as preparation method and application thereof
CN105004683B (en) chromium-IgE chelate as well as preparation method and application thereof
CN104987407B (en) cadmium-IgG chelate as well as preparation method and application thereof
CN104987403A (en) Nickel-hemoglobin chelate as well as preparation method and application thereof
CN104987414A (en) Nickel-IgM chelate as well as preparation method and application thereof
CN104987404A (en) Nickel-IgG chelate as well as preparation method and application thereof
CN105017430B (en) Nickel chelate immune complex and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20151021

RJ01 Rejection of invention patent application after publication